Skip to main content

Dexchlorpheniramine / methscopolamine / pseudoephedrine Pregnancy and Breastfeeding Warnings

Brand names: D-Hist D, DuraHist D, Histatab D

Dexchlorpheniramine / methscopolamine / pseudoephedrine Pregnancy Warnings

Dexchlorpheniramine/methscopolamine/pseudoephedrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Dexchlorpheniramine/methscopolamine/pseudoephedrine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Dexchlorpheniramine / methscopolamine / pseudoephedrine Breastfeeding Warnings

There are no data on the excretion of dexchlorpheniramine/methscopolamine/pseudoephedrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

Does Dexchlorpheniramine/methscopolamine/pseudoephedrine interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

References for pregnancy information

  1. (2022) "Product Information. Durahist D (dexchlorpheniramine/methscopolamine/PSE)." Kowa Pharmaceuticals America (formerly ProEthic)

References for breastfeeding information

  1. (2022) "Product Information. Durahist D (dexchlorpheniramine/methscopolamine/PSE)." Kowa Pharmaceuticals America (formerly ProEthic)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer